Laura Sutcliffe will join the Wall Street bank in July. Citi head of research Paul McTaggart has found himself a new head of ...

Citi head of research Paul McTaggart has found himself a new head of healthcare.

The Australian operations of Goldman Sachs experienced a fall in net profit last year to $4.4m, despite the Wall Street ...

Goldman Sachs (NYSE:GS), a leading global investment banking firm, revealed its Q1 2025 GAAP earnings on 2025-04-14. The Q1 2025 results exceeded analyst expectations with diluted EPS (GAAP ...

Goldman Sachs Gr GS is set to give its latest quarterly earnings report on Monday, 2025-04-14. Here's what investors need to know before the announcement. Analysts estimate that Goldman Sachs Gr ...

Goldman Sachs Group Inc. economists said they now see a 65% chance of a US recession in the next 12 months, citing President Donald Trump’s tariffs on US trading partners. “We think the White ...

Goldman Sachs reversed its prediction that the United States will enter a recession following President Donald Trump‘s decision to pause reciprocal tariffs on dozens of countries for 90 days. “ ...

Goldman Sachs economists have revised their S&P 500 targets, aligning with other Wall Street forecasters. They currently characterize the selloff as an event-driven bear market, noting its ...

Goldman Sachs has slashed its oil prices forecasts again and now expects Brent Crude to average below $60 per barrel next year, at $58, amid recession risks, slowing demand, and more supply from ...

As major stock indices dip into bear market territory or near the 20% decline threshold, Goldman Sachs has offered insight into the current market conditions. The financial institution highlighted ...

As major U.S. stock indices fall into or near bear market territory, defined by a 20% drop from recent highs, Goldman Sachs (GS) provided some context on what this downturn could mean. The ...

Goldamn Sachs has initiated coverage of two Indian ... as of 12 pm. For Suven Pharma, Goldman has given a target price of Rs 1,350 per share, predicting a sharp rebound from FY26.